Get started
Author

Kar Ying Yong

Observed names: K Y Yong, Yong, Kar Ying
Institution: Ministry of Health
ORCID: 0000-0003-0508-4883
Observed ORCID: 0000-0003-0508-4883
OpenAlex ID: A5005292215
High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma
2023 · Katharine L. Lewis, Lasse H. Jakobsen, et al. · Journal of Clinical Oncology · 49
High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma
2021 · Shin Yeu Ong, Sanjay de Mel, et al. · Blood Cancer Journal · 33
PDF
High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients
2021 · Katharine Louise Lewis, Lasse H. Jakobsen, et al. · Blood · 18
NT-proBNP Cut-off Values for Risk Stratification in Acute MI and Comparison with Other Risk Assessment Scores
2022 · Shirley Siang Ning Tan, Keng Tat Koh, et al. · Journal of Asian Pacific Society of Cardiology · 3
PDF
Haemophilia care and outcome in a major haemophilia treatment centre in Malaysia.
2021 · Y L Boo, C C K Liam, et al. · PubMed · 3
The magnitude of tyrosine kinase inhibitor induced cytopaenia on normal haematopoietic tissues in chronic myeloid leukaemia patients
2022 · Jew Win Kuan, Si Yuan Ng, et al. · International Journal of Laboratory Hematology · 1
Falsely “high” serum cobalamin level in subacute combined degeneration of spinal cord secondary to pernicious anemia masquerading as myelodysplastic syndrome
2022 · Kar Ying Yong, Eng Soo Yap, et al. · Neurology and Clinical Neuroscience · 1
Subcutaneous mycosis presenting as a non- healing left calf ulcer in an immunocompromised patient.
2017 · A S O Tang, K Y Yong, et al. · PubMed · 1
Ten‐Year Outcome of a Patient With Concurrent Pelvic Myeloid Sarcoma and Underlying Chronic Myeloid Leukaemia in Chronic Phase: A Case Report and Literature Review
2026 · Kar Ying Yong, Soo How Lim, et al. · Cancer Reports
Prescribing patterns, efficacy and safety of DOAC usage in a tertiary hospital
2021 · Kar Ying Yong, Shirlene Leow, et al. · National University of Singapore
A randomized controlled trial comparing peginterferon-α-2a versus observation after stopping tyrosine kinase inhibitor in chronic myeloid leukemia patients with deep molecular response for at least two years
2020 · Jew Win Kuan, Kian Meng Chang, et al.
PDF
Treatment Outcome and a Practical 10-Point Prognostic Index in Adult Patients with Non-M3 Acute Myeloid Leukemia: A Retrospective, Multicenter Study in Malaysia
2019 · Tze Shin Leong, Sen Mui Tan, et al. · Blood
Works count: 14
Citation count: 109
H-index: 3
I10-index: 3
Year
Topic
Type